Quotient Limited (QTNTQ)

Market Cap	275.47K
Revenue (ttm)	37.41M
Net Income (ttm)	-124.03M
Shares Out	n/a
EPS (ttm)	-3.77
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	0.0320
Day's Range	n/a
52-Week Range	0.0320 - 0.5100
Beta	2.45
Analysts	Buy
Price Target	n/a
Earnings Date	n/a

About QTNTQ

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, w...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Apr 25, 2014
• Employees: 432
• Stock Exchange: OTCMKTS
• Ticker Symbol: QTNTQ

Financial Performance

In 2022, Quotient's revenue was $38.51 million, a decrease of -11.22% compared to the previous year's $43.38 million. Losses were -$125.13 million, 15.4% more than in 2021.